Patent 8669047 was granted and assigned to Theranos on March, 2014 by the United States Patent and Trademark Office.
The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.